Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Future treatment options for squamous cell lung cancer

Paul Paik • 3 Jun 2019
ASCO 2019
Lung Cancer

Speaking from the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL, Paul Paik of the Memorial Sloan Kettering Cancer Center, New York, NY discusses future direction for squamous cell lung cancer treatment and the potential for immunotherapy.

More from Paul Paik

2:48
VISION trial: subset efficacy analyses of tepotinib for NSCLC
Paul Paik • 26 Jan 2021
2:49
The challenges of treating METex14 NSCLC
Paul Paik • 26 Jan 2021
0:55
Squamous cell lung cancer: gene targets
Paul Paik • 3 Jun 2019
1:04
Tepotinib: advanced non-small cell lung cancer
Paul Paik • 4 Jul 2019

Related Videos

0:45
Assessing treatment options for lung cancer with interstitial lung disease
Matthew Hatton • 18 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
2:26
Targeting KRAS mutations in lung cancer
Thomas Newsom-Davis • 18 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals